Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points | NHLBI Trans-Omics for Precision Medicine Skip to main content

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points

Short Name
ECLIPSE
Institution(s)
Harvard University
Type of Omics
WGS
Approx. Sample Size 2400 (ph3)
Disease/Phenotype
COPD
Starting Phase
Phase 3
TOPMed Accession #
phs001472
Omics Center(s) Phase 3
McDonnell Genome Institute
Phases Involved
3
PI

Ed Silverman
Data Set contact(s)
Michael Cho
Ed Silverman
Project
ECLIPSE